<div id="readability-page-1">11:17 AM EST, 12/12/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower late Friday morning, falling 1% to 1,646.41 on the S&amp;P Europe Select ADR Index, which is up 1.3% so far this week.From continental Europe, the gainers were led by telecommunications operator Telefonica ( TEF ) and pharmaceutical company Ascendis Pharma ( ASND ) , which rose 1.5% and 1% respectively. They were followed by energy company Equinor ( EQNR ) and pharmaceutical company Novo Nordisk ( NVO ) , which were up 0.6% and 0.3% respectively.The decliners from continental Europe were led by biopharmaceutical companies Cellectis ( CLLS ) and DBV Technologies ( DBVT ) , which fell 8.4% and 3.1% respectively. They were followed by telecommunications company Nokia ( NOK ) and medical device maker EDAP TMS ( EDAP ) , which were down 2.6% and 0.6% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Autolus Therapeutics ( AUTL ) , which advanced 8.3% and 1.9% respectively. They were followed by software firm Endava ( DAVA ) and hospitality company InterContinental Hotels Group ( IHG ) , which increased 1.7% and 1.1% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and tobacco company British American Tobacco ( BTI ) , which lost 11.9% and 3.2% respectively. They were followed by insurance company Prudential (PUK) and lender Lloyds Banking Group ( LYG ) , which dropped 2.4% and 1.7% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

Akari治療

DBV 科技

Ascendis制藥

BDRX

英美煙草

在美國交易的歐洲股票以美國存託憑證形式下跌了 1%，儘管本週上漲了 1.3%。值得注意的漲幅股票包括 Telefonica、Ascendis Pharma、Equinor 和 Novo Nordisk。下跌的股票包括 Cellectis、DBV Technologies、諾基亞和 EDAP TMS。在英國和愛爾蘭，Akari Therapeutics 和 Autolus Therapeutics 領漲，而 Biodexa Pharmaceuticals 和英美煙草則出現了顯著下跌

在美國以美國存託憑證形式交易的歐洲股票在週五的交易中下跌；但本週股價仍然上漲